Report Description


Forecast Period


Market Size (2022)

USD126.07 million

CAGR (2023-2028)


Fastest Growing Segment

Vascular Stent

Largest Market



Market Overview

Indonesia Stent Market has valued at USD 126.07 million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.33% through 2028. a stent is a small, flexible tube-like device that is used to support and open up a narrowed or blocked blood vessel, duct, or hollow organ. Stents are often used in various medical procedures to improve blood flow, relieve obstructions, and ensure the proper functioning of the affected area. They are commonly employed in the cardiovascular system, but they can also be used in other parts of the body. tents are medical devices used in a variety of healthcare applications to treat and manage various conditions that involve narrowed or blocked passages within the body. Here are some of the common uses of stents such as Coronary Artery Disease (CAD) Treatment, Peripheral Artery Disease (PAD) Treatment, Aneurysm Repair, Biliary and Pancreatic Obstruction, Urological Disorders, Gastrointestinal Conditions, Airway Obstruction, Dialysis Access, Esophageal Disorders, Tracheobronchial Conditions, etc. Stents are widely used in the treatment of heart conditions, specifically in the context of coronary artery disease (CAD). Coronary artery disease occurs when the arteries that supply oxygen-rich blood to the heart muscle become narrowed or blocked due to the buildup of plaque, which is a combination of cholesterol, fat, and other substances. Stents play a crucial role in restoring blood flow and alleviating the effects of coronary artery disease.

The stents are useful for the heart for Restoring Blood Flow. Stents are inserted into narrowed or blocked coronary arteries during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent acts as a scaffold, holding the artery open and preventing it from collapsing. This restoration of blood flow helps ensure that the heart muscle receives an adequate supply of oxygen and nutrients. Coronary artery disease can lead to symptoms such as chest pain (angina) or shortness of breath, especially during physical activity. By improving blood flow to the heart, stents can alleviate these symptoms, allowing patients to engage in daily activities with less discomfort. When a coronary artery becomes completely blocked by a blood clot, it can lead to a heart attack. By keeping the artery open and reducing the risk of abrupt closure, stents help minimize the chances of a heart attack occurring.

Restenosis refers to the re-narrowing of a previously treated artery after angioplasty. Many modern stents are designed with drug-eluting capabilities. These drug-eluting stents release medications that help inhibit the growth of cells within the artery, reducing the likelihood of restenosis and the need for additional procedures. The use of stents in conjunction with other medical therapies can improve the long-term outcomes for individuals with coronary artery disease. Stents can help prevent the progression of the disease and reduce the need for repeat procedures. Stent placement is a minimally invasive procedure that often requires only a small incision in the skin. This approach typically results in shorter hospital stays, faster recovery times, and less pain compared to open-heart surgery. Stents come in various sizes and designs to suit the specific characteristics of the patient's arteries. This customization allows for precise placement and optimal treatment outcomes. These reasons are projected to further drive the demand for Indonesia Stent Market and subsequently foster the growth of the Indonesia Stent Market.

 Key Market Drivers

Growing Cardiovascular Disease Burden

The growing cardiovascular disease burden in Indonesia has a significant impact on the growth of the stent market in the country. Cardiovascular diseases (CVDs), particularly coronary artery disease (CAD), are a major public health concern in Indonesia and many other countries. Here's how the increasing burden of cardiovascular disease influences the growth of the stent market in Indonesia. As the prevalence of cardiovascular diseases, such as CAD, increases, there is a higher demand for medical interventions to address these conditions. Stents play a crucial role in the treatment of CAD by restoring blood flow to blocked or narrowed coronary arteries. The greater the number of individuals with cardiovascular diseases, the greater the need for stent procedures. The rising burden of cardiovascular diseases translates to an increased number of individuals requiring medical interventions. This, in turn, leads to a higher volume of stent placement procedures, contributing to the growth of the stent market.

The growing cardiovascular disease burden has spurred research and development efforts in stent technology. Manufacturers are constantly working on improving stent designs, materials, and drug-eluting capabilities to enhance their effectiveness and safety. The introduction of advanced stent technologies to address the specific needs of patients with complex cardiovascular conditions can drive market growth. Efforts to improve healthcare infrastructure and access to medical services in Indonesia can lead to earlier diagnosis and intervention for cardiovascular diseases. This means that more patients are identified as candidates for stent procedures, contributing to the expansion of the stent market.

Advancements in Medical Technology

Advancements in medical technology play a significant role in influencing the growth of the stent market in Indonesia. As new technologies and innovations emerge, they have a direct impact on the design, efficacy, safety, and availability of stent products. Here's how advancements in medical technology are influencing the growth of the stent market in Indonesia. The technological advancements have led to the development of stents with improved designs that offer better flexibility, radial strength, and conformability to the blood vessels. These advancements enhance the effectiveness of stent placement procedures and contribute to better patient outcomes. Additionally, the drug-eluting stents release medications over time to prevent the re-narrowing of the treated artery (restenosis) after stent placement. The introduction of DES has significantly reduced the need for repeat procedures and improved long-term results, driving the adoption of stent procedures.

Bioabsorbable stents gradually dissolve over time, leaving behind a natural vessel structure. These stents eliminate the need for a permanent metallic implant and offer potential benefits in terms of reduced long-term complications. Advances in nanotechnology have led to the development of specialized coatings for stents. These coatings can improve biocompatibility, reduce inflammation, and enhance drug delivery, resulting in better patient outcomes and reduced complications. 3D printing technology allows for the creation of patient-specific stents, tailored to the individual's anatomical characteristics. This personalization can lead to more effective treatments and improved patient experiences. Advancements in minimally invasive techniques, such as the use of smaller catheters and better imaging technologies, have made stent placement procedures less invasive and safer for patients. These techniques contribute to shorter hospital stays, faster recovery times, and increased patient satisfaction. These drivers are expected to bolster the growth of Indonesia Stent Market.

Increasing Healthcare Expenditure

Increasing healthcare expenditure can have a significant influence on the growth of the stent market in Indonesia. Healthcare expenditure refers to the amount of money spent by individuals, governments, and organizations on healthcare services, treatments, and medical devices. As healthcare expenditure increases, there is a greater capacity to invest in advanced medical technologies and treatments, including stent placement procedures. This improved access to healthcare services can drive demand for stent interventions, especially among patients who might not have previously had access to such treatments. Increased healthcare spending often leads to the expansion and improvement of medical facilities, including hospitals and clinics. This expansion can result in enhanced infrastructure for performing stent procedures and other cardiovascular interventions. A larger healthcare budget allows for the allocation of resources toward the purchase of medical devices such as stents. This increased demand can drive manufacturers to provide a wider range of stent options, leading to greater market growth. Rising healthcare expenditure may include funds allocated for training and education of healthcare professionals. This can lead to a more skilled workforce capable of performing stent procedures, contributing to the growth of the stent market. Increased funding for healthcare can support research and development efforts in the field of medical devices, including stents.

This can lead to the development of innovative stent technologies that cater to specific patient needs, further driving the growth of Indonesia Stent Market. Higher healthcare expenditure can lead to the expansion of health insurance coverage, making stent procedures more accessible and affordable for a larger portion of the population. This can stimulate demand for stent interventions. A well-funded healthcare system can attract patients from neighboring countries seeking advanced medical treatments. Medical tourism can contribute to increased demand for stent procedures and other cardiovascular interventions. Governments may allocate more resources to address the rising burden of cardiovascular diseases. Initiatives to improve heart health awareness, preventive measures, and access to treatments like stent procedures can drive market growth. A growing economy and increased disposable income levels can lead to higher healthcare spending by individuals. This can translate to more individuals seeking advanced medical interventions, including stent placements. Sustained increases in healthcare expenditure can lead to long-term improvements in healthcare infrastructure, which in turn can facilitate the growth and sustainability of the Indonesia stent market.

Download Free Sample Report

Key Market Challenges

Economic Constraints

Economic constraints can have a notable influence on the growth of the stent market in Indonesia. Limited healthcare budgets and financial challenges can impact various aspects of the stent market, from patient access to medical technology to the overall demand for stent procedures. Stent placement procedures can be costly, encompassing expenses related to the stent itself, medical facilities, healthcare professionals, and post-procedure care. Economic constraints may limit the ability of some patients to afford these procedures, resulting in reduced demand. Limited healthcare budgets may lead to prioritization of essential healthcare services over elective procedures like stent placement. This can result in delayed or deferred stent procedures, impacting the overall growth of Indonesia Stent market. Economic constraints can lead to disparities in access to healthcare services. Patients with limited financial resources may face barriers to accessing specialized cardiovascular care, including stent interventions. Additionally, Healthcare institutions operating under economic constraints may struggle to invest in advanced medical technologies, including stent devices. This can hinder the adoption of newer and more effective stent options. Inadequate insurance coverage for stent procedures can place a financial burden on patients. Patients may be discouraged from seeking stent interventions if they are concerned about high out-of-pocket costs. Economic challenges may impact the development and expansion of healthcare infrastructure, particularly in rural or underserved areas. This can limit the availability of facilities equipped to perform stent procedures. Economic constraints may lead to reduced investments in research and development for innovative stent technologies. This can limit the introduction of new and advanced stent options to the market. Economic limitations may affect the attractiveness of Indonesia as a medical tourism destination for stent procedures. Patients from other countries may choose alternative destinations with more favorable economic conditions.

Regulatory Challenges

Regulatory challenges can significantly influence the growth of the stent market in Indonesia. Regulatory processes, approvals, and compliance requirements can impact the availability, accessibility, and adoption of stent procedures and related medical technologies. Lengthy and complex regulatory approval processes can lead to delays in introducing new stent technologies to the market. These delays can hinder the timely availability of advanced stent options for patients and healthcare providers. Stringent regulatory requirements may discourage manufacturers from introducing their products to the Indonesian market. This can result in a limited selection of stent devices, potentially limiting treatment options for patients and healthcare professionals. Regulatory challenges can discourage investment in research and development of innovative stent technologies. Manufacturers may be reluctant to invest resources in developing new products if regulatory hurdles are perceived as too burdensome. The complying with complex regulatory requirements often requires significant financial resources. Manufacturers may need to invest in additional testing, documentation, and administrative processes, leading to higher costs that can impact pricing and affordability. If Indonesia's regulatory standards diverge significantly from international norms, it can complicate the import and use of stent devices that adhere to global standards, potentially limiting the options available to patients. Inconsistent or unclear regulatory frameworks can create uncertainty for manufacturers seeking to enter the Indonesian market. This uncertainty can deter investment and slow down the introduction of new stent technologies. Additionally, the stringent regulatory requirements for conducting clinical trials can limit the availability of data needed to evaluate the safety and efficacy of new stent technologies in the Indonesian population which in turn propell the growth of Indonesia Stent Market in the forecast period.

Key Market Trends

Rise in Minimally Invasive Procedures

The rise in minimally invasive procedures is significantly influencing the growth of the stent market in Indonesia. Minimally invasive procedures, including stent placement, offer several advantages over traditional open surgeries, making them increasingly attractive to both patients and healthcare providers. Minimally invasive procedures are associated with smaller incisions, less scarring, reduced pain, and quicker recovery times compared to open surgeries. As patients become more informed about these benefits, they are more likely to choose minimally invasive options like stent placement, contributing to increased demand. Minimally invasive procedures often result in shorter hospital stays, allowing patients to return to their daily activities sooner. This can lead to higher patient satisfaction and a higher likelihood of choosing stent procedures over alternative treatments. Minimally invasive procedures are generally associated with fewer post-operative complications, such as wound infections and bleeding. This improved safety profile can make stent placement a more appealing option for patients and healthcare providers. The quicker recovery period associated with minimally invasive procedures allows patients to resume work and other activities more rapidly. This can have economic implications and may make stent procedures more attractive to working individuals. Minimally invasive procedures can be particularly beneficial for elderly or high-risk patients who may not tolerate the physical stress of traditional open surgeries well. Stent placement provides a less invasive alternative for these populations.

Segmental Insights

Product Type Insights

In 2022, the Stent Market was dominated by the vascular stent segment and is predicted to continue expanding over the coming years.  The rising prevalence of cardiovascular diseases across the country can be attributed to various diseases. Cardiovascular diseases, such as coronary artery disease and peripheral artery disease, are among the leading causes of morbidity and mortality worldwide, including in Indonesia. Vascular stents are primarily used to treat these conditions, making them a crucial segment of the stent market. The vascular stents, particularly drug-eluting stents, have demonstrated significant clinical efficacy in reducing restenosis and improving patient outcomes in coronary and peripheral interventions. This clinical evidence supports the widespread adoption of vascular stents. Vascular stents encompass coronary stents, peripheral stents, and neurovascular stents. Within the coronary stent category, there are subdivisions: bare metal stents, drug-eluting stents, and bioresorbable stents. The market has witnessed an upsurge in demand for drug-eluting stents due to the introduction of innovative drugs by manufacturers, offering multiple advantages in the region. Drug-eluting stents are composed of a combination of polymer coating, anti-restenotic drug, and a conventional metallic stent that is blended with polymer and gradually released over a specified duration.

Material Type Insights

In 2022, the Stent Market was dominated by metal segment and is predicted to continue expanding over the coming years. During the application of stents in surgical procedure, it is necessary to check the hypersensitivity of material. Metals stents are biocompatible to avoid corrosion, immune response, and radio opaque. Metal stents have demonstrated efficacy in treating coronary and peripheral artery diseases. Drug-eluting metallic stents, in particular, have shown significant reductions in restenosis rates compared to bare-metal stents, leading to improved patient outcomes.

Download Free Sample Report

Regional Insights

The Bali region has established itself as the leader in the Indonesia Stent Market. This can be attributed to significant demand of medical devices such as stents. Additionally, this region has significant healthcare infrastructure and demand for medical interventions. Furthermore, the cities such as Jakarta, Surabaya, Bandung, and Denpasar have been known for advanced healthcare facilities, tend to have higher utilization of medical devices across the regions. Therefore, this is expected to drive the growth of the Stent Market in Indonesia.

Recent Developments

  • In Dec 2022, the biodegradable coronary stents were developed to treat coronary artery diseases. Bare-metal and drug-eluting stents show promising clinical outcomes, in recent years, numerous preclinical and clinical trials have evaluated the properties of bioresorbable stents, including polymer and magnesium-based stents. Three-dimensional (3D) printed-shape-memory polymeric materials enable the self-deployment of stents and provide a novel approach for individualized treatment.
  • In July 2022, the development of drug-coated stents is employed in almost all instances of percutaneous coronary revascularization and have demonstrated their superiority over balloon angioplasty or stents without drug coatings. The configurations of these stents are consistently advancing to optimize their effectiveness and ensure safety.

Key Market Players

  • PT B. Braun Medical Indonesia
  • PT Boston Scientific Indonesia
  • PT Medtronic Indonesia
  • PT Becton Dickinson Indonesia
  • PT Abbott Indonesia
  • PT Multidaya Medika
  • PT Terumo Indonesia

 By Product Type

  By Material Type

  By End User

By Region

By Region

  • Vascular Stent
  • Non-Vascular Stent
  • Metal
  • Polymer
  • Hospital & Clinics
  • Ambulatory Care Centers
  • Others
  • Bali
  • Java
  • Kalimantan
  • Sulawesi
  • Indonesian Papua
  • Sumatra
  • Nusa Tenggara
  • Moluccas
  • Saudi Arabia
  • UAE
  • Qatar
  • Kuwait
  • Bahrain
  • Rest of Middle East
Report Scope:

In this report, the Indonesia Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Indonesia Stent Market, By Product Type:

o   Vascular Stent

o   Non-Vascular Stent

·         Indonesia Stent Market, By Material Type:

o   Metal

o   Polymer

·         Indonesia Stent Market, By End User:

o   Hospital & Clinics

o   Ambulatory Care Centers

o   Others

·         Indonesia Stent Market, By Region:

o   Bali

o   Java

o   Kalimantan

o   Sulawesi

o   Indonesian Papua

o   Sumatra

o   Nusa Tenggara

o   Moluccas

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Indonesia Stent Market.

Available Customizations:

Indonesia Stent Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Indonesia Stent Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Indonesia Stent Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product Type (Vascular Stent, Non-Vascular Stents)

5.2.2.     By Material Type (Metal, Polymer)

5.2.3.     By End User (Hospital & Clinics, Ambulatory Care Centers, Others)

5.2.4.     By Region (Bali, Java, Kalimantan, Sulawesi, Indonesian Papua, Sumatra, Nusa Tenggara, Moluccas)

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1.     By Product Type

5.3.2.     By Material Type

5.3.3.     By End User

6.    Indonesia Vascular Stents Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Material Type (Metal, Polymer)

6.2.2.     By Type (Coronary Stents, Peripheral Stents, Neurovascular Stents)

6.2.3.     By End User (Hospital & Clinics, Ambulatory Care Centers, Others)

7.    Indonesia Non-Vascular Stents Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Material Type (Metal, Polymer)

7.2.2.     By Type (Gastrointestinal Stents, Urological Stents, Pulmonary (Airway) Stents)

7.2.3.     By End User (Hospital & Clinics, Ambulatory Care Centers, Others)

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

9.1.  Merger & Acquisition

9.2.  Product Development

9.3.  Recent Developments

10.  Policy & Regulatory Landscape

11.  Indonesia Economic Profile

12.  Competitive Landscape

12.1.              Business Overview

12.2.              Company Snapshot

12.3.              Products & Services

12.4.              Financials (As Reported)

12.5.              Recent Developments

12.5.1.  PT B. Braun Medical Indonesia

12.5.2.  Pt Boston Scientific Indonesia

12.5.3.  PT Medtronic Indonesia

12.5.4.  PT Becton Dickinson Indonesia

12.5.5.  PT Abbott Indonesia

12.5.6.  PT Multidaya Medika

12.5.7.  PT Terumo Indonesia

13.  Strategic Recommendations

Figures and Tables

Frequently asked questions


The market size of the Indonesia Stent Market was estimated to be USD126.07 million in 2022.


PT B. Braun Medical Indonesia, PT Boston Scientific Indonesia, PT Medtronic Indonesia, PT Becton Dickinson Indonesia, PT Abbott Indonesia, PT Multidaya Medika, PT Terumo Indonesia are some of the key players operating in the Indonesia Stent Market.


The limited healthcare infrastructure, the regulatory challenges, and health insurance coverage are the major challenges faced by the Indonesia Stent Market in the upcoming years.


Rising cardiovascular disease burden, health infrastructure development and rapid urbanization are majorly driving the growth of the Indonesia Stent Market.


Sakshi Bajaal

Business Consultant
Press Release

Indonesia Stents Market to be dominated by Vascular Stent in Indonesia through 2028

Nov, 2023

Growing incidence of cardiovascular cases are expected to drive the Indonesia Stent Market in the forecast period, 2024-2028.